Download PDF
J Pediatr Infect Dis 2016; 11(02): 051-052
DOI: 10.1055/s-0036-1593838
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Q Fever and Kawasaki Disease with Coronary Artery Dilatation

Paul Heaton
1   Department of Paediatrics, Yeovil District Hospital, Yeovil, United Kingdom
,
Jolanta Bernatoniene
2   Department of Paediatric Infectious and Immunology, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
,
Gareth J. Morgan
3   Department of Cardiology, University of Colorado, Denver, Colorado, United States
4   Heart Institute, Colorado Children's Hospital, Denver, Colorado, United States
› Author Affiliations
Further Information

Publication History

08 September 2016

20 September 2016

Publication Date:
25 October 2016 (online)

    Permissions and Reprints

Abstract

We report a case of Q fever due to Coxiella burnetii infection coexisting with Kawasaki disease (KD) in a previously healthy 6-year-old boy. Diagnosis of both pathologies was complex on account of nonspecific multiorgan involvement. The infection was successfully treated with ciprofloxacin but despite intravenous immunoglobulin coronary artery dilatation developed consequent to KD.

Keywords

Q fever - Kawasaki disease - coronary artery dilatation
 

  • References

  • 1 Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis 2002; 2 (11) 686-691
    CrossrefPubMedGoogle Scholar
  • 2 Lupoglazoff JM, Brouqui P, Magnier S, Hvass U, Casasoprana A. Q fever tricuspid valve endocarditis. Arch Dis Child 1997; 77 (5) 448-449
    CrossrefPubMedGoogle Scholar
  • 3 al-Hajjar S, Hussain Qadri SM, al-Sabban E, Jäger C. Coxiella burnetii endocarditis in a child. Pediatr Infect Dis J 1997; 16 (9) 911-913
    CrossrefPubMedGoogle Scholar
  • 4 Pinsky RL, Fishbein DB, Greene CR, Gensheimer KF. An outbreak of cat-associated Q fever in the United States. J Infect Dis 1991; 164 (1) 202-204
    CrossrefPubMedGoogle Scholar
  • 5 Wisniewski HJ, Krumbiegel ER. Q fever in the Milwaukee area. 3. Epidemiological studies of Q fever in humans. Arch Environ Health 1970; 21 (1) 66-70
    CrossrefPubMedGoogle Scholar
  • 6 Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12 (4) 518-553
    PubMedGoogle Scholar
  • 7 Yim D, Curtis N, Cheung M, Burgner D. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health 2013; 49 (9) 704-708
    CrossrefPubMedGoogle Scholar
  • 8 Yim D, Curtis N, Cheung M, Burgner D. An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes. J Paediatr Child Health 2013; 49 (8) 614-623
    CrossrefPubMedGoogle Scholar
  • 9 Newburger JW, Takahashi M, Beiser AS , et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324 (23) 1633-1639
    CrossrefPubMedGoogle Scholar
  • 10 Pierre R, Sue-Ho R, Watson D. Kawasaki syndrome in Jamaica. Pediatr Infect Dis J 2000; 19 (6) 539-543
    CrossrefPubMedGoogle Scholar
  • 11 Ohgimi C, Tanaka R, Oh-ishi T. A case report of acute Q fever showing Kawasaki disease-like symptoms in a 9-year-old girl [in Japanese]. Kansenshogaku Zasshi 2009; 83 (3) 245-250
    CrossrefPubMedGoogle Scholar
  • 12 Kafetzis DA, Maltezou HC, Constantopoulou I, Antonaki G, Liapi G, Mathioudakis I. Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group. Pediatr Infect Dis J 2001; 20 (7) 703-706
    CrossrefPubMedGoogle Scholar
  • 13 Swaby ED, Fisher-Hoch S, Lambert HP, Stern H. Is Kawasaki disease a variant of Q fever?. Lancet 1980; 2 (8186) 146
    PubMedGoogle Scholar
  • 14 Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child 2014; 99 (1) 74-83
    CrossrefPubMedGoogle Scholar
  • 15 Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol 2010; 22 (5) 551-560
    CrossrefPubMedGoogle Scholar